EUVIMEDEUVIMED entdecken
Crossref

Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation

Heba F Salem, Heba M Aboud, Mostafa M Abdellatif, Heba A Abou-Taleb

Journal of Pharmaceutical Sciences · 2024

DOI: 10.1016/j.xphs.2024.02.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2024. Verfasst von Heba F Salem und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Hauptthemen laut MEDLINE: Donepezil, Alzheimer Disease, Hyaluronic Acid, Administration, Intranasal. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease is the most serious neurodegenerative disorder characterized by cognitive and memorial defects alongside deterioration in behavioral, thinking and social skills. Donepezil hydrochloride (DPZ) is one of the current two FDA-approved cholinesterase inhibitors used for the management of Alzheimer's disease. The current study aimed to formulate hyaluronic acid-coated transfersomes containing DPZ (DPZ-HA-TFS) for brain delivery through the intranasal pathway to surpass its oral-correlated GIT side effects. DPZ-HA-TFS were produced using a thin film hydration method and optimized with a 24 factorial design. The influence of formulation parameters on vesicle diameter, entrapment, cumulative release after 8 h, and ex vivo nasal diffusion after 24 h was studied. The optimal formulation was then evaluated for morphology, stability, histopathology and in vivo biodistribution studies. The optimized DPZ-HA-TFS formulation elicited an acceptable vesicle size (227.5 nm) with 75.83% entrapment efficiency, 37.94% cumulative release after 8 h, 547.49 µg/cm2 permeated through nasal mucosa after 24 h and adequate stability. Histopathological analysis revealed that the formulated DPZ-HA-TFS was nontoxic and tolerable for intranasal delivery. Intranasally administered DPZ-HA-TFS manifested significantly superior values for drug targeting index (5.08), drug targeting efficiency (508.25%) and direct nose-to-brain transport percentage (80.32%). DPZ-HA-TFS might be deemed as a promising intranasal nano-cargo for DPZ cerebral delivery to tackle Alzheimer's disease safely, steadily and in a non-invasive long-term pattern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DonepezilAlzheimer DiseaseHyaluronic AcidAdministration, IntranasalBrainCholinesterase InhibitorsNasal MucosaAnimalsDrug LiberationTissue DistributionRatsMaleDrug Delivery SystemsNanoparticlesDrug CarriersRats, WistarParticle Size

Stichwörter der Autor:innen

Alzheimer's diseaseDonepezil hydrochlorideHyaluronic acidIntranasalPharmacokineticsTransfersomes

Substanzen

DonepezilHyaluronic AcidCholinesterase InhibitorsDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Electronic address: heba.aboud@pharm.bsu.edu.eg.
  • Department of Pharmaceutics, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Merit University, Sohag, Egypt.

Zitieren

APA

Salem, H. F., Aboud, H. M., Abdellatif, M. M., & Abou-Taleb, H. A. (2024). Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2024.02.014

Vancouver

Salem HF, Aboud HM, Abdellatif MM, Abou-Taleb HA. Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation. Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.xphs.2024.02.014

BibTeX
@article{Salem2024,
  author = {Salem, Heba F and Aboud, Heba M and Abdellatif, Mostafa M and Abou-Taleb, Heba A},
  title = {Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1016/j.xphs.2024.02.014}
}
Kostenlos starten →